Built Once, Used Many Times
Why Reuse Beats Reinvention on a Real Platform A shared substrate doesn’t compound anything on its own. It compounds only when the workflows running on top of it get reused instead of rebuilt. Blog 1 made the case that platforms compound because they have real anatomy underneath them – schema, taxonomy, workflow expertise, ontology, intelligence […]
One Substrate, Eight Workflows
How a Single Semantic Layer Powers Solix EAI Pharma’s Discovery Stack If a platform’s anatomy is real, adding an eighth capability shouldn’t require rebuilding the first seven. Our last post argued, alongside Patrick Grady’s two-part “On Platforms” series, that AI compounds only when it sits on a real anatomy — schema, taxonomy, workflow expertise, ontology, […]
Tools Automate. Platforms Compound.
Why Architecture — and Anatomy — Beat a Pile of Point Solutions in Pharma AI Every pharma R&D organization now owns more AI tools than it did three years ago — and, by most internal accounts, less clarity about what any of them are learning together. That paradox is the subject of a two-part series […]
The $2.6 Billion Lesson: What Pharma’s Failed Programs Are Trying to Tell Us
Every terminated drug program leaves behind a fingerprint of why it failed. AI can now read those fingerprints — and turn them into the blueprint for the next success Pharmaceutical R&D generates failure at an extraordinary rate — and buries it. >90% of discovery programs never reach an IND. ~70% of Phase II trials fail […]